Assertio to acquire Spectrum Pharmaceuticals | Crain's Chicago Business
The all-stock deal would bring oncology drug Rolvedon into Assertio's drug portfolio.
Source: chicagobusiness.com
📰 Boston Based Spectrum News
Boston Based Spectrum News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boston Based Spectrum. Real-time updates on events, politics, business and more.
Biotech Firm Slashes 75% of Staff After FDA Rejects Drug for Rare Lung Cancer
In rejecting Spectrum Pharmaceuticals drug poziotinib, the FDA said the biotech needs to generate more data from another clinical trial. Instead, Spectrum is turning the company’s focus to commercializing its recently approved product for treating a common cancer complication.
Coherus Biosciences A Spectrum Pharmaceuticals Spectrum Pharmaceuticals Boston Based Spectrum Spectrum President Weight Loss
Source: medcitynews.com
FDA advisory committee issues back to back negative votes on two cancer drugs
Spectrum Pharmaceuticals and Oncopeptides each received separate negative advisory committee votes for their respective cancer drugs. In other recent regulatory news, clinical trial holds were placed and lifted and the FDA is seeking public comment on its draft guidance for including children in clinical trials.
Eli Lilly Spectrum Pharmaceuticals Boston Based Spectrum Ferring Pharmaceutical Larimar Therapeutics Weight Loss
Source: medcitynews.com